223 related articles for article (PubMed ID: 16387454)
1. Absence of viral envelope proteins in equine herpesvirus 1-infected blood mononuclear cells during cell-associated viremia.
van der Meulen K; Caij B; Pensaert M; Nauwynck H
Vet Microbiol; 2006 Mar; 113(3-4):265-73. PubMed ID: 16387454
[TBL] [Abstract][Full Text] [Related]
2. Antibody and cellular immune responses following DNA vaccination and EHV-1 infection of ponies.
Soboll G; Hussey SB; Whalley JM; Allen GP; Koen MT; Santucci N; Fraser DG; Macklin MD; Swain WF; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):81-95. PubMed ID: 16549215
[TBL] [Abstract][Full Text] [Related]
3. Cell-mediated immunity evaluation in foals infected with virulent equine herpesvirus-1 by multi-parameter flow cytometry.
Platt R; Sponseller BA; Chiang YW; Roth JA
Vet Immunol Immunopathol; 2010 Jun; 135(3-4):275-81. PubMed ID: 20116862
[TBL] [Abstract][Full Text] [Related]
4. Expression of late viral proteins is restricted in nasal mucosal leucocytes but not in epithelial cells during early-stage equine herpes virus-1 infection.
Gryspeerdt AC; Vandekerckhove AP; Baghi HB; Van de Walle GR; Nauwynck HJ
Vet J; 2012 Aug; 193(2):576-8. PubMed ID: 22425309
[TBL] [Abstract][Full Text] [Related]
5. Equine herpesvirus-1 infected peripheral blood mononuclear cell subpopulations during viremia.
Wilsterman S; Soboll-Hussey G; Lunn DP; Ashton LV; Callan RJ; Hussey SB; Rao S; Goehring LS
Vet Microbiol; 2011 Apr; 149(1-2):40-7. PubMed ID: 21093993
[TBL] [Abstract][Full Text] [Related]
6. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination.
Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC
Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075
[TBL] [Abstract][Full Text] [Related]
7. Equine interferon gamma synthesis in lymphocytes after in vivo infection and in vitro stimulation with EHV-1.
Paillot R; Daly JM; Juillard V; Minke JM; Hannant D; Kydd JH
Vaccine; 2005 Aug; 23(36):4541-51. PubMed ID: 15913852
[TBL] [Abstract][Full Text] [Related]
8. Cytokine responses to EHV-1 infection in immune and non-immune ponies.
Coombs DK; Patton T; Kohler AK; Soboll G; Breathnach C; Townsend HG; Lunn DP
Vet Immunol Immunopathol; 2006 May; 111(1-2):109-16. PubMed ID: 16473413
[TBL] [Abstract][Full Text] [Related]
9. Serum antibody responses to equine herpesvirus 1 glycoprotein D in horses, pregnant mares and young foals.
Foote CE; Love DN; Gilkerson JR; Rota J; Trevor-Jones P; Ruitenberg KM; Wellington JE; Whalley JM
Vet Immunol Immunopathol; 2005 May; 105(1-2):47-57. PubMed ID: 15797474
[TBL] [Abstract][Full Text] [Related]
10. In vitro cytotoxicity of serum and peripheral blood leukocytes for equine herpesvirus type 1-infected target cells.
Wilks CR
Am J Vet Res; 1977 Jan; 38(1):117-21. PubMed ID: 189645
[TBL] [Abstract][Full Text] [Related]
11. Equine herpesvirus type-1 modulates CCL2, CCL3, CCL5, CXCL9, and CXCL10 chemokine expression.
Wimer CL; Damiani A; Osterrieder N; Wagner B
Vet Immunol Immunopathol; 2011 Apr; 140(3-4):266-74. PubMed ID: 21349590
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility complex class I-restricted cytotoxic T-lymphocyte responses in horses infected with equine herpesvirus 1.
Allen G; Yeargan M; Costa LR; Cross R
J Virol; 1995 Jan; 69(1):606-12. PubMed ID: 7983765
[TBL] [Abstract][Full Text] [Related]
13. Role of gB and pUS3 in Equine Herpesvirus 1 Transfer between Peripheral Blood Mononuclear Cells and Endothelial Cells: a Dynamic In Vitro Model.
Spiesschaert B; Goldenbogen B; Taferner S; Schade M; Mahmoud M; Klipp E; Osterrieder N; Azab W
J Virol; 2015 Dec; 89(23):11899-908. PubMed ID: 26378176
[TBL] [Abstract][Full Text] [Related]
14. Pathogenic potential of equine alphaherpesviruses: the importance of the mononuclear cell compartment in disease outcome.
Osterrieder N; Van de Walle GR
Vet Microbiol; 2010 Jun; 143(1):21-8. PubMed ID: 20202764
[TBL] [Abstract][Full Text] [Related]
15. Control of equine infectious anemia virus is not dependent on ADCC mediating antibodies.
Tschetter JR; Byrne KM; Perryman LE; McGuire TC
Virology; 1997 Apr; 230(2):275-80. PubMed ID: 9143283
[TBL] [Abstract][Full Text] [Related]
16. Pre-infection frequencies of equine herpesvirus-1 specific, cytotoxic T lymphocytes correlate with protection against abortion following experimental infection of pregnant mares.
Kydd JH; Wattrang E; Hannant D
Vet Immunol Immunopathol; 2003 Dec; 96(3-4):207-17. PubMed ID: 14592733
[TBL] [Abstract][Full Text] [Related]
17. Characterisation of CTL and IFN-gamma synthesis in ponies following vaccination with a NYVAC-based construct coding for EHV-1 immediate early gene, followed by challenge infection.
Paillot R; Ellis SA; Daly JM; Audonnet JC; Minke JM; Davis-Poynter N; Hannant D; Kydd JH
Vaccine; 2006 Mar; 24(10):1490-500. PubMed ID: 16269205
[TBL] [Abstract][Full Text] [Related]
18. Plasma D-dimer concentrations during experimental EHV-1 infection of horses.
Goehring LS; Soboll Hussey G; Gomez Diez M; Benedict K; Maxwell LK; Morley PS; Sloet van Oldruitenborgh-Oosterbaan MM; Lunn DP
J Vet Intern Med; 2013; 27(6):1535-42. PubMed ID: 24112533
[TBL] [Abstract][Full Text] [Related]
19. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains.
Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN
Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140
[TBL] [Abstract][Full Text] [Related]
20. Equine herpesvirus-1 infection induces IFN-gamma production by equine T lymphocyte subsets.
Breathnach CC; Soboll G; Suresh M; Lunn DP
Vet Immunol Immunopathol; 2005 Feb; 103(3-4):207-15. PubMed ID: 15621307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]